National Institutes of Health

Description

The purpose of this Funding Opportunity Announcement (FOA) is to continue to increase the amount of publicly available, high-quality data describing structures and affinities of protein-drug ligand complexes -data vital for development, validation, and benchmarking of drug docking and screening software. Accurate and robust methods for in silico drug screening are expected to speed drug discovery and reduce drug development cost by focusing experimental efforts on the most promising candidate compounds. The ability to predict side effects resulting from off-target binding and to increase repurposing of existing pharmaceuticals is an additional expected benefit.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH OER Webmaster <br/>FBOWebmaster@OD.NIH.GOV <br/>
FBOWebmaster@OD.NIH.GOV